Boston Scientific Corp (BSX) stock
BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3051% below fair value
$44.34+0.14 (+0.32%)
Close on Nov 13, 2026Market cap $64.26BP/E 18.8Yield –
Boston Scientific gross margin
Gross margin is gross profit as a percentage of revenue.
Boston Scientific's gross margin for the twelve months ending Sep 30, 2026 was 69.1%. For fiscal 2025 it was 69.0%, against 68.6% the year before. The highest annual figure on record is 72.0% in fiscal 2007.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 69.0% | +0.4 |
| FY2024 | Dec 31, 2024 | 68.6% | −0.9 |
| FY2023 | Dec 31, 2023 | 69.5% | +0.7 |
| FY2022 | Dec 31, 2022 | 68.8% | +0.0 |
| FY2021 | Dec 31, 2021 | 68.8% | +3.7 |
| FY2020 | Dec 31, 2020 | 65.0% | −5.9 |
| FY2019 | Dec 31, 2019 | 71.0% | −0.4 |
| FY2018 | Dec 31, 2018 | 71.4% | +0.0 |
| FY2017 | Dec 31, 2017 | 71.3% | +0.2 |
| FY2016 | Dec 31, 2016 | 71.1% | +0.2 |
| FY2015 | Dec 31, 2015 | 70.9% | +1.7 |
| FY2014 | Dec 31, 2014 | 69.3% | −1.0 |
| FY2013 | Dec 31, 2013 | 70.3% | −0.2 |
| FY2012 | Dec 31, 2012 | 70.4% | +5.3 |
| FY2011 | Dec 31, 2011 | 65.1% | −1.6 |
| FY2010 | Dec 31, 2010 | 66.7% | −1.8 |
| FY2009 | Dec 31, 2009 | 68.5% | −0.8 |
| FY2008 | Dec 31, 2008 | 69.3% | −2.6 |
| FY2007 | Dec 31, 2007 | 72.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 66.7% | −3.2 |
| Q2 FY2026 | Jun 30, 2026 | 70.7% | +3.1 |
| Q1 FY2026 | Mar 31, 2026 | 69.5% | +0.6 |
| Q4 FY2025 | Dec 31, 2025 | 69.6% | +1.7 |
| Q3 FY2025 | Sep 30, 2025 | 69.9% | +1.1 |
| Q2 FY2025 | Jun 30, 2025 | 67.7% | −1.5 |
| Q1 FY2025 | Mar 31, 2025 | 68.8% | +0.2 |
| Q4 FY2024 | Dec 31, 2024 | 67.9% | −1.4 |
| Q3 FY2024 | Sep 30, 2024 | 68.8% | +0.0 |
| Q2 FY2024 | Jun 30, 2024 | 69.2% | −1.5 |
| Q1 FY2024 | Mar 31, 2024 | 68.7% | −0.6 |
| Q4 FY2023 | Dec 31, 2023 | 69.2% | +0.4 |
| Q3 FY2023 | Sep 30, 2023 | 68.8% | −0.3 |
| Q2 FY2023 | Jun 30, 2023 | 70.6% | +1.8 |
| Q1 FY2023 | Mar 31, 2023 | 69.3% | +0.9 |
| Q4 FY2022 | Dec 31, 2022 | 68.8% | −0.1 |
| Q3 FY2022 | Sep 30, 2022 | 69.1% | −0.2 |
| Q2 FY2022 | Jun 30, 2022 | 68.8% | −0.5 |
| Q1 FY2022 | Mar 31, 2022 | 68.4% | +0.9 |
| Q4 FY2021 | Dec 31, 2021 | 68.9% | +5.9 |
| Q3 FY2021 | Sep 30, 2021 | 69.3% | +2.0 |
| Q2 FY2021 | Jun 30, 2021 | 69.3% | +8.8 |
| Q1 FY2021 | Mar 31, 2021 | 67.5% | −0.8 |
| Q4 FY2020 | Dec 31, 2020 | 63.0% | −7.7 |
| Q3 FY2020 | Sep 30, 2020 | 67.3% | −4.0 |
| Q2 FY2020 | Jun 30, 2020 | 60.5% | −10.7 |
| Q1 FY2020 | Mar 31, 2020 | 68.3% | −2.4 |
| Q4 FY2019 | Dec 31, 2019 | 70.7% | −0.8 |
| Q3 FY2019 | Sep 30, 2019 | 71.3% | −0.6 |
| Q2 FY2019 | Jun 30, 2019 | 71.2% | +0.9 |
| Q1 FY2019 | Mar 31, 2019 | 70.7% | −1.0 |
| Q4 FY2018 | Dec 31, 2018 | 71.5% | −0.5 |
| Q3 FY2018 | Sep 30, 2018 | 71.9% | +0.5 |
| Q2 FY2018 | Jun 30, 2018 | 70.3% | −1.7 |
| Q1 FY2018 | Mar 31, 2018 | 71.8% | +1.8 |
| Q4 FY2017 | Dec 31, 2017 | 72.0% | −0.6 |
| Q3 FY2017 | Sep 30, 2017 | 71.3% | – |
| Q2 FY2017 | Jun 30, 2017 | 72.0% | – |
| Q1 FY2017 | Mar 31, 2017 | 69.9% | – |
| Q4 FY2016 | Dec 31, 2016 | 72.6% | – |
See a number that looks wrong?